Data / Federal rules / 2025-02793

Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients

The Health and Human Services Department published this final rule in the Federal Register on February 19, 2025. It took effect on March 21, 2025. Comments closed on February 28, 2025.

SpecStream is the live web data engine for teams and agents. It reads every rule and proposed rule in the Federal Register each morning, and this page is that reading. Name your industry once and new rules, comment deadlines and effective dates arrive in your sheet, CRM, Slack or agent as they are published.

Get new rules for your industry

What the agency says

In the January 17, 2025, issue of the Federal Register, the Drug Enforcement Administration and the Department of Health and Human Services published two final rules related to the practice of telemedicine, titled "Expansion of Buprenorphine Treatment via Telemedicine Encounter" and "Continuity of Care via Telemedicine for Veterans Affairs Patients." These final rules were scheduled to become final on February 18, 2025. In accordance with the Presidential Memorandum of January 20, 2025, titled "Regulatory Freeze Pending Review," the Drug Enforcement Administration and the Department of Health and Human Services are delaying the effective dates of these two final rules to March 21, 2025, and are soliciting public comments specifically regarding this delayed effective date.

Key facts

Document number: 2025-02793
Type: Final rule
Action: Final rule; delay of effective dates and request for comments
Agency: Justice Department; Drug Enforcement Administration; Health and Human Services Department
Published: February 19, 2025
Takes effect: March 21, 2025
Comments due: February 28, 2025
Dates: Effective date delay: As of February 14, 2025, the effective date of the two final rules amending CFR part 1306 and 42 CFR part 12 published in the Federal Register on January 17, 2025, at 90 FR 6504 and 90 FR 6523, respectively, are delayed to March 21, 2025.
Docket: Docket No. DEA-948; DEA-407VA
Regulation ID (RIN): 1117-AB40; 1117-AB78; 1117-AB88
Code of Federal Regulations: 21 CFR 1306; 42 CFR 12
Significant: Yes, under Executive Order 12866
Pages: 3

The document on federalregister.gov PDF

Other documents from the Health and Human Services Department

Document	Type	Published
Action Levels for Cadmium in Processed Food Intended for Babies and Young Children; Draft Guidance for Industry; Availability 2026-21670	Proposed rule	Oct 23
Hazard Analysis and Risk-Based Preventive Controls for Human Food; Draft Guidance for Industry; Availability 2026-21669	Proposed rule	Oct 23
Medicare Program; Implementation of Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act, 2026 2026-21420	Proposed rule	Oct 20
Further Reducing Bureaucracy and Burden From the Administration for Native Americans 2026-21004	Proposed rule	Oct 14
Food Additives Permitted in Feed and Drinking Water of Animals; Chromium Propionate 2026-20979	Final rule	Oct 14
Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods 2026-20848 · significant	Final rule	Oct 13
Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections Using Home-Collected Specimens 2026-20727	Final rule	Oct 9
Medical Devices; Cardiovascular Devices; Classification of the Infant Pulse Rate and Oxygen Saturation Monitor for Over-the-Counter Use 2026-20726	Final rule	Oct 9

Everything from the Health and Human Services Department · Published in February 2025

Read from the Federal Register API, last updated 2026-10-23. The document on federalregister.gov is the official record; dates and dockets can change through later corrections. Free to reuse with credit to SpecStream under CC BY 4.0.